Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

ME

23andMe Holding Co

Apr 24 • 04:00PM ET

0.4671

Dollar change -0.0266
Percentage change -5.39	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN SCHA VTWO VHT PRFZ ONEQ BFOR

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.10	Insider Own	41.89%	Shs Outstand	293.02M	Perf Week	31.13%
Market Cap	225.57M	Forward P/E	-	EPS next Y	-0.67	Insider Trans	-0.25%	Shs Float	280.62M	Perf Month	3.57%
Income	-521.97M	PEG	-	EPS next Q	-0.17	Inst Own	23.09%	Short Float	11.72%	Perf Quarter	-33.23%
Sales	247.99M	P/S	0.91	EPS this Y	-62.88%	Inst Trans	7.13%	Short Ratio	4.30	Perf Half Y	-40.66%
Book/sh	0.78	P/B	0.60	EPS next Y	40.58%	ROA	-63.93%	Short Interest	32.88M	Perf Year	-76.65%
Cash/sh	0.50	P/C	0.93	EPS next 5Y	-	ROE	-92.53%	52W Range	0.35 - 2.21	Perf YTD	-48.87%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-8.86%	ROI	-116.61%	52W High	-78.86%	Beta	1.26
Dividend TTM	-	Quick Ratio	1.96	Sales past 5Y	-21.82%	Gross Margin	32.43%	52W Low	33.46%	ATR (14)	0.07
Dividend Ex-Date	-	Current Ratio	2.07	EPS Y/Y TTM	-56.13%	Oper. Margin	-133.76%	RSI (14)	48.29	Volatility	23.71% 12.99%
Employees	816	Debt/Eq	0.21	Sales Y/Y TTM	-19.40%	Profit Margin	-210.48%	Recom	2.00	Target Price	1.24
Option/Short	Yes / Yes	LT Debt/Eq	0.19	EPS Q/Q	-185.06%	Payout	-	Rel Volume	0.38	Prev Close	0.49
Sales Surprise	-17.18%	EPS Surprise	-314.58%	Sales Q/Q	-33.15%	Earnings	Feb 07 AMC	Avg Volume	7.65M	Price	0.47
SMA20	-1.44%	SMA50	-12.42%	SMA200	-49.03%	Trades		Volume	2,941,040	Change	-5.39%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-29-22	Initiated	Berenberg	Buy	$7
Sep-22-22	Initiated	Cowen	Outperform	$6
Nov-15-21	Downgrade	Citigroup	Buy → Neutral	$12 → $13
Aug-17-21	Initiated	Credit Suisse	Outperform	$13
Jul-12-21	Initiated	Citigroup	Buy	$14

Today 04:05PM	23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire) -5.39%
Apr-23-24 05:21AM	This Technology Company Is Being Acquired at a Shocking 207% Premium -- and These 2 Stocks Could Be Next (Motley Fool) +7.23%
Apr-19-24 03:43PM	23andMe CEO Anne Wojcicki Says Shes Weighing Buyout Bid (Barrons.com)
Apr-18-24 11:09AM	Stocks to Watch Thursday: TSMC, Netflix, Nvidia, Tesla (The Wall Street Journal) +41.91%
10:36AM	23andMe Stock Jumps on News of Plans to Take It Private (The Wall Street Journal)
10:01AM	Loading…
10:01AM	23andMe CEO Anne Wojcicki Plans to Take Company Private (The Wall Street Journal)
10:00AM	23andMe Jumps as CEO Floats Taking DNA Tester Private (Bloomberg)
08:00AM	23andMe announces CEO's intention to pursue a potential take-private (GlobeNewswire)
06:35AM	23andMe CEO plans to take company private (MedTech Dive)
Apr-17-24 11:12PM	23andMe CEO Wojcicki considering taking firm private, filing shows (Reuters) -8.69%
Apr-05-24 04:05PM	23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024 (GlobeNewswire)
Mar-24-24 03:23AM	Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead? (Motley Fool)
Mar-20-24 07:30AM	23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6 (GlobeNewswire)
Mar-19-24 08:00AM	23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago (GlobeNewswire)
Mar-06-24 07:30AM	23andMe Launches New Genetic Reports on Common Forms of Cancer (GlobeNewswire) +5.90%
04:30PM	Loading…
Mar-05-24 04:30PM	23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024 (GlobeNewswire) -6.86%
Feb-23-24 05:15AM	20 Most Valuable Digital Health Companies In The US (Insider Monkey) -5.83%
Feb-13-24 09:53AM	Is 23andMe Stock a Smart Buy Right Now? (Motley Fool)
Feb-08-24 01:13PM	23andMe Stock Slides After DNA-Testing Company's Disappointing Results (The Wall Street Journal) -13.05%
08:59AM	23andMe Holding Co. (NASDAQ:ME) Q3 2024 Earnings Call Transcript (Insider Monkey)
08:27AM	Q3 2024 23andMe Holding Co. Earnings Call (Thomson Reuters StreetEvents)
Feb-07-24 09:44PM	How 23AndMe Went From a $6 Billion Valuation to a Penny Stock (WSJ)
06:55PM	23andMe Mulls Possible Split, Shares Fall After Disappointing Results (The Wall Street Journal)
05:42PM	Struggling 23andMe Is Exploring Splitting the DNA Company in Two (Bloomberg)
04:54PM	23andMe Holding Co (ME) Faces Revenue Decline and Net Loss in Q3 FY24 (GuruFocus.com)
04:01PM	23andMe Reports Third Quarter Fiscal 2024 Financial Results (GlobeNewswire)
Feb-05-24 03:23PM	SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy (Benzinga) -5.26%
07:35AM	Main Street is still investing like its 2023 (CNN Business)
Feb-02-24 04:30PM	23andMe is low on cash and its stock is worth pennies. The CEO wants another chance (CNN Business)
Jan-31-24 11:10AM	Lawsuits for Consumers with Accounts at 23andMe Holding Co. (NASDAQ: ME) in connection with Data Breach announced by the Shareholders Foundation (GlobeNewswire)
07:30AM	Loading…
07:30AM	23andMe Announces FDA Clearance of IND Application for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6 (GlobeNewswire)
05:30AM	23andMes Fall From $6 Billion to Nearly $0 (The Wall Street Journal)
Jan-30-24 10:12PM	23andMe Launches Month-Long Initiative to Amplify ARRAY's Seat16 Program for Acclaimed Film ORIGIN by Ava DuVernay (GlobeNewswire)
Jan-24-24 04:05PM	23andMe to Report FY2024 Third Quarter Financial Results (GlobeNewswire)
Jan-21-24 06:11AM	The 3 Worst Stock Investments I Ever Made -- and What I Learned From Them (Motley Fool)
Jan-03-24 04:30PM	23andMe blames users for data breach, citing recycled passwords (Fox Business) -8.04%
Dec-26-23 07:12PM	5 Most Promising Small-Cap Stocks According to Analysts (Insider Monkey)
Dec-19-23 08:00AM	23andMe announces further expansion of 23ME-00610 Phase 1/2a clinical trial in advanced neuroendocrine and ovarian cancer patient cohorts (GlobeNewswire) +10.49%
Dec-13-23 04:00AM	The Danger in Genetic-Data Breaches: You Cant Change Your DNA. (Barrons.com)
Dec-08-23 04:52PM	23andMe makes a controversial move that customers won't like (TheStreet.com)
Dec-07-23 11:04AM	Cyberattacks surge in 2023, as millions fall victim to ransomware: Report (Yahoo Finance) -9.94%
Dec-06-23 05:14PM	23andMe isn't the only DNA testing company that faced a data leak (TheStreet.com)
11:55AM	23andMe data leak reveals dangers of DNA testing kits (TheStreet.com)
Dec-05-23 09:00PM	23andMe Hack Is a Wake-Up Call for Your Password Habits (The Wall Street Journal)
06:27PM	Starbucks, 23andMe, JetBlue and Spirit: Trending tickers (Yahoo Finance Video)
01:30PM	Hackers access profiles of nearly 7 million 23andMe customers (CNN Business)
01:26AM	PRESS DIGEST-New York Times business news - Dec 5 (Reuters)
Nov-25-23 09:45AM	The 3 Best Digital Health Stocks for Personalized Medicine (InvestorPlace)
Nov-10-23 12:13PM	23andMe Holding Co. (NASDAQ:ME) Q2 2024 Earnings Call Transcript (Insider Monkey)
Nov-08-23 04:05PM	23andMe Reports Second Quarter Fiscal 2024 Financial Results (GlobeNewswire)
Nov-07-23 08:00AM	23andMe Launches Total Health , its Comprehensive, Prevention-Based Health Membership (GlobeNewswire)
Nov-06-23 08:00AM	23andMe Announces Updated Safety and Preliminary Efficacy Data From the Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1 (GlobeNewswire)
Oct-31-23 08:00AM	23andMe Launches Health Action Plan to Provide Personalized Recommendations Based on Genetic and Other Health Data (GlobeNewswire) +9.70%
Oct-30-23 08:00AM	23andMe Announces Collaboration Extension with a New Data Licensing Agreement with GSK (GlobeNewswire)
Oct-25-23 04:05PM	23andMe to Report FY2024 Second Quarter Financial Results (GlobeNewswire)
Oct-24-23 06:15PM	23andMe notifies customers of data breach into its 'DNA Relatives' feature (Reuters)
Oct-23-23 09:50AM	Fighting the Silent Killer: Innovative Therapies for Pancreatic Cancer on the Rise (PR Newswire)
Oct-20-23 01:58PM	US senator asks 23andMe for details after reported data for sale online (Reuters)
Oct-16-23 03:40PM	Hackers could use your stolen 23andMe DNA data as a weapon (TheStreet.com)
Oct-09-23 07:00PM	23andMe profile information of some customers surfaces on dark web (Fox Business) -6.27%
Oct-06-23 07:51PM	Hacker Puts 23andMe User Data Up for Sale on the Internet (Bloomberg)
05:28PM	Hackers advertise sale of 23andMe data on leaked data forum (Reuters)
Sep-27-23 04:05PM	23andMe Announces Poster Presentations on 23ME-00610, an Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancers (SITC) 2023 Annual Meeting (GlobeNewswire)
Sep-14-23 07:00AM	23andMe and Sickle Cell 101 Collaborate to Expand Sickle Cell Awareness Program (GlobeNewswire)
Sep-01-23 09:57AM	23andMe receives FDA approval to test for cancer variants (Yahoo Finance Video)
Aug-31-23 05:28PM	23andMe Granted New FDA Clearance to Report Additional BRCA Variants (GlobeNewswire)
Aug-25-23 05:10AM	Better AI Biotech Stock: Recursion Pharmaceuticals vs. 23andMe (Motley Fool) +5.71%
Aug-22-23 05:32AM	23andMe: DNA testing kit company needs drug discovery (Financial Times) -9.65%
Aug-09-23 05:24PM	Why 23andMe Holding Stock Plummeted by 13% Today (Motley Fool) -12.93%
Aug-08-23 04:05PM	23andMe Reports FY2024 First Quarter Financial Results (GlobeNewswire)
Jul-25-23 04:05PM	23andMe to Report FY2024 First Quarter Financial Results (GlobeNewswire)
Jul-20-23 09:23AM	23andMe Releases New FDA-Cleared Genetic Report on Simvastatin, a Commonly Prescribed Statin (GlobeNewswire)
Jun-26-23 03:00AM	Shake Shack Stock Blows Through the Roof. 23andMe Tumbles. (Barrons.com)
Jun-21-23 07:00AM	23andMe Releases New Report Revealing Genetic Likelihood of Experiencing Panic Attacks (GlobeNewswire)
Jun-17-23 07:00AM	3 Gene Testing Stocks to Buy Before They Take Off (InvestorPlace)
Jun-14-23 11:40AM	10 DNA Stocks Billionaires Are Loading Up On (Insider Monkey) -5.10%
May-26-23 08:00AM	Q4 2023 23andMe Holding Co. Earnings Call (Thomson Reuters StreetEvents)
May-25-23 04:05PM	23andMe Reports FY2023 Fourth Quarter and Full Year Financial Results (GlobeNewswire)
May-23-23 09:53AM	Better Diversified Biotech Stock: 23andMe vs. Fulgent Genetics (Motley Fool)
May-19-23 06:40AM	Hero or Zero? 3 High-Risk Penny Stocks to Make You Rich or Broke. (InvestorPlace)
May-16-23 10:59AM	Here's Why We're Not Too Worried About 23andMe Holding's (NASDAQ:ME) Cash Burn Situation (Simply Wall St.)
07:00AM	New 23andMe survey reveals nine out of ten physicians in the U.S. believe genetics play an important part of a patients complete health picture (GlobeNewswire)
May-11-23 04:05PM	23andMe to Report FY2023 Fourth Quarter and Full Year Financial Results (GlobeNewswire)
May-09-23 07:00AM	23andMe Releases New Report Revealing Likelihood of Developing Lupus (GlobeNewswire)
May-08-23 07:00AM	Reza Afkhami Joins 23andMe as Chief Corporate Development Officer (GlobeNewswire)
May-01-23 08:20PM	Why the human genome could be health cares holy grail (Yahoo Finance Video)
11:54AM	23andMe CEO: We see more opportunities in DNA partnerships (Yahoo Finance)
Apr-30-23 09:38PM	2023 Milken Conference: the issues facing investors today (Yahoo Finance Video)
Apr-27-23 09:43AM	3 things to watch at next week's Milken Conference (Yahoo Finance Video)
Apr-19-23 08:57AM	23andMe Holding Co.'s (NASDAQ:ME) Share Price Could Signal Some Risk (Simply Wall St.)
Apr-14-23 04:05PM	23andMe Announces Phase 1 Results from the First-in-Human Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1 (GlobeNewswire)
Apr-11-23 07:00AM	Morehouse School of Medicine, Sickle Cell Foundation of Georgia and 23andMe Launch Sickle Cell Carrier Status Awareness Program (GlobeNewswire)
Mar-29-23 07:01AM	23andMe Publishes Inaugural Environmental, Social and Governance Report (PR Newswire)
Mar-24-23 07:00AM	23andMe Aims To Raise Awareness of Lipoprotein(a), a Little-Known Genetic Risk Factor for Cardiovascular Disease (GlobeNewswire)
Mar-23-23 06:22AM	23andMe Holding (NASDAQ:ME) shareholders have endured a 41% loss from investing in the stock a year ago (Simply Wall St.)
Mar-22-23 10:23AM	3 Key Ways That Artificial Intelligence Will Disrupt Biotech Stocks (Motley Fool)
Mar-17-23 10:15AM	WSJ. Magazine Celebrates Style & Tech in Silicon Valley (The Wall Street Journal)
Mar-14-23 04:30PM	23andMe Announces Presentation of Phase 1 Clinical Data for 23ME-00610, an Investigational Antibody Targeting CD200R1, at the American Association for Cancer Research (AACR) Annual Meeting 2023 (GlobeNewswire)
Mar-09-23 10:07AM	AI Revolution on the Horizon: 2 High-Potential Growth Stocks to Watch in 2023 (Motley Fool)
09:00AM	New 23andMe Surveys Find Most People and Doctors Agree that Genetic Testing Offers Promise for More Personalized Healthcare (GlobeNewswire)

23andMe Holding Co. is a consumer genetics and research company, which engages in assisting people to access, understand, and benefit from the human genome. It operates through the Consumer and Research Services, and Therapeutics segments. The Consumer and Research Services segment consists of Personal Genome Service, Telehealth Business, and Research Services. The Therapeutics segment focuses on the genetic insights of genetic and phenotypic information. The company was founded by Anne E. Wojcickiin 2006 and is headquartered in South San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
HIBBS KATHY L	Chief Administrative Officer	Apr 18 '24	Option Exercise	0.42	38,548	16,190	1,290,863	Apr 19 04:20 PM
HIBBS KATHY L	Chief Administrative Officer	Apr 18 '24	Sale	0.47	38,548	18,148	1,252,315	Apr 19 04:20 PM
HIBBS KATHY L	Chief Administrative Officer	Apr 04 '24	Option Exercise	0.42	38,548	16,190	1,290,863	Apr 05 04:14 PM
HIBBS KATHY L	Chief Administrative Officer	Apr 04 '24	Sale	0.50	38,548	19,282	1,252,315	Apr 05 04:14 PM
HIBBS KATHY L	Chief Administrative Officer	Mar 21 '24	Option Exercise	0.42	38,548	16,190	1,290,863	Mar 22 07:22 PM
HIBBS KATHY L	Chief Administrative Officer	Mar 21 '24	Sale	0.46	38,548	17,894	1,252,315	Mar 22 07:22 PM
HIBBS KATHY L	Chief Administrative Officer	Mar 07 '24	Option Exercise	0.42	38,548	16,190	1,290,863	Mar 11 04:09 PM
HIBBS KATHY L	Chief Administrative Officer	Mar 07 '24	Sale	0.53	38,548	20,430	1,252,315	Mar 11 04:09 PM
HIBBS KATHY L	Chief Administrative Officer	Feb 22 '24	Option Exercise	0.42	38,548	16,190	1,278,375	Feb 23 05:09 PM
HIBBS KATHY L	Chief Administrative Officer	Feb 22 '24	Sale	0.61	38,548	23,325	1,239,827	Feb 23 05:09 PM
HIBBS KATHY L	Chief Administrative Officer	Feb 15 '24	Option Exercise	0.42	38,548	16,190	1,318,897	Feb 16 04:47 PM
HIBBS KATHY L	Chief Administrative Officer	Feb 15 '24	Sale	0.78	38,548	30,210	1,280,349	Feb 16 04:47 PM
HIBBS KATHY L	Chief Administrative Officer	Jan 25 '24	Option Exercise	0.42	38,548	16,190	1,318,897	Jan 26 08:24 PM
HIBBS KATHY L	Chief Administrative Officer	Jan 25 '24	Sale	0.73	38,548	27,997	1,280,349	Jan 26 08:24 PM
HIBBS KATHY L	Chief Administrative Officer	Jan 11 '24	Option Exercise	0.42	38,548	16,190	1,318,897	Jan 12 06:51 PM
HIBBS KATHY L	Chief Administrative Officer	Jan 11 '24	Sale	0.72	38,548	27,581	1,280,349	Jan 12 06:51 PM
HIBBS KATHY L	Chief Administrative Officer	Dec 28 '23	Option Exercise	0.42	38,548	16,190	1,318,897	Dec 29 04:04 PM
HIBBS KATHY L	Chief Administrative Officer	Dec 28 '23	Sale	0.93	38,548	35,904	1,280,349	Dec 29 04:04 PM
HIBBS KATHY L	Chief Administrative Officer	Dec 14 '23	Option Exercise	0.42	38,548	16,190	1,318,897	Dec 18 04:17 PM
HIBBS KATHY L	Chief Administrative Officer	Dec 14 '23	Sale	0.97	38,548	37,222	1,280,349	Dec 18 04:17 PM
HIBBS KATHY L	Chief Administrative Officer	Nov 30 '23	Option Exercise	0.42	38,548	16,190	1,318,897	Dec 01 04:22 PM
HIBBS KATHY L	Chief Administrative Officer	Nov 30 '23	Sale	0.88	38,548	33,753	1,280,349	Dec 01 04:22 PM
HIBBS KATHY L	Chief Administrative Officer	Nov 16 '23	Option Exercise	0.42	38,548	16,190	1,323,524	Nov 17 04:25 PM
HIBBS KATHY L	Chief Administrative Officer	Nov 16 '23	Sale	0.77	38,548	29,732	1,284,976	Nov 17 04:25 PM
HIBBS KATHY L	Chief Administrative Officer	Nov 02 '23	Option Exercise	0.42	38,548	16,190	1,323,524	Nov 03 07:02 PM
HIBBS KATHY L	Chief Administrative Officer	Nov 02 '23	Sale	0.87	38,548	33,437	1,284,976	Nov 03 07:02 PM
HIBBS KATHY L	Chief Administrative Officer	Oct 19 '23	Option Exercise	0.42	38,548	16,190	1,323,524	Oct 20 05:28 PM
HIBBS KATHY L	Chief Administrative Officer	Oct 19 '23	Sale	0.81	38,548	31,397	1,284,976	Oct 20 05:28 PM
HIBBS KATHY L	Chief Administrative Officer	Oct 05 '23	Option Exercise	0.42	38,548	16,190	1,323,524	Oct 06 05:16 PM
HIBBS KATHY L	Chief Administrative Officer	Oct 05 '23	Sale	0.84	38,548	32,407	1,284,976	Oct 06 05:16 PM
HIBBS KATHY L	Chief Administrative Officer	Sep 21 '23	Option Exercise	0.42	38,548	16,190	1,323,524	Sep 25 04:00 PM
HIBBS KATHY L	Chief Administrative Officer	Sep 21 '23	Sale	1.00	38,548	38,583	1,284,976	Sep 25 04:00 PM
HIBBS KATHY L	Chief Administrative Officer	Sep 07 '23	Option Exercise	0.42	40,894	17,175	299,880	Sep 11 04:04 PM
HIBBS KATHY L	Chief Administrative Officer	Sep 07 '23	Sale	1.06	40,894	43,483	258,984	Sep 11 04:04 PM
Richards William G	Head of Therapeutics Discovery	Sep 05 '23	Sale	1.08	2,538	2,741	211,041	Sep 06 05:01 PM
HIBBS KATHY L	Chief Administrative Officer	Aug 24 '23	Option Exercise	0.42	40,894	17,175	293,406	Aug 25 04:57 PM
HIBBS KATHY L	Chief Administrative Officer	Aug 24 '23	Sale	1.05	40,894	43,119	252,512	Aug 25 04:57 PM
HIBBS KATHY L	Chief Administrative Officer	Aug 15 '23	Option Exercise	0.42	40,894	17,175	298,034	Aug 16 04:51 PM
HIBBS KATHY L	Chief Administrative Officer	Aug 15 '23	Sale	1.32	40,894	53,939	257,140	Aug 16 04:51 PM
HIBBS KATHY L	Chief Administrative Officer	Jul 27 '23	Option Exercise	0.42	40,894	17,175	298,034	Jul 31 04:23 PM
HIBBS KATHY L	Chief Administrative Officer	Jul 27 '23	Sale	1.89	40,894	77,257	257,140	Jul 31 04:23 PM
HIBBS KATHY L	Chief Administrative Officer	Jul 13 '23	Option Exercise	0.42	40,894	17,175	298,034	Jul 14 04:33 PM
HIBBS KATHY L	Chief Administrative Officer	Jul 13 '23	Sale	1.82	40,894	74,239	257,140	Jul 14 04:33 PM
HIBBS KATHY L	Chief Administrative Officer	Jun 29 '23	Option Exercise	0.42	40,894	17,175	298,034	Jun 30 04:22 PM
HIBBS KATHY L	Chief Administrative Officer	Jun 29 '23	Sale	1.72	40,894	70,432	257,140	Jun 30 04:22 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ME

23andMe Holding Co

Upgrade your FINVIZ experience